Authors:
REBATTU P
PUJOL JL
ARDIET C
QUENTIN X
DROZ JP
DUMORTIER A
KHIAL F
SCHULLER MP
Citation: P. Rebattu et al., COMBINATION OF DOCETAXEL (DTX) AND GEMCITABINE (G) IN PATIENTS WITH INOPERABLE OR METASTATIC NONSMALL CELL LUNG-CANCER (NSCLC) - A PHASE-I STUDY, Annals of oncology, 9, 1998, pp. 361-361
Authors:
GUILLOT A
ARDIET C
DUMORTIER A
ZANETTA S
REBATTU P
DUBIN F
ASSADOURIAN S
DROZ JP
Citation: A. Guillot et al., PHASE-I TRIAL OF DOCETAXEL AND METHOTREXATE COMBINATION IN PATIENTS WITH METASTATIC AND UROTHELIAL EPIDERMOID CARCINOMA, Annals of oncology, 9, 1998, pp. 395-395
Authors:
HIGHLEY MS
SCHRIJVERS D
ARDIET C
VANOOSTEROM AT
DEBRUIJN EA
Citation: Ms. Highley et al., PHARMACOKINETICS OF THE MITOMYCIN KW-2149 - GENERATION OF THE ACTIVE METABOLITE M-18, Annals of oncology, 9, 1998, pp. 480-480
Authors:
TRANCHAND B
CATIMEL G
LUCAS C
SARKANY M
BASTIAN G
EVENE E
GUASTALLA JP
NEGRIER S
REBATTU P
DUMORTIER A
FOY M
GROSSIN F
MAZIER B
FROUDARAKIS M
BARBET N
CLAVEL M
ARDIET C
Citation: B. Tranchand et al., PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF S9788, A NEW MULTIDRUG-RESISTANCE REVERSAL AGENT GIVEN ALONE AND IN COMBINATION WITH DOXORUBICIN TO PATIENTS WITH ADVANCED SOLID TUMORS, Cancer chemotherapy and pharmacology, 41(4), 1998, pp. 281-291
Authors:
FREYER G
LIGNEAU B
TRANCHAND B
ARDIET C
SERREDEBEAUVAIS F
TRILLETLENOIR V
Citation: G. Freyer et al., PHARMACOKINETIC STUDIES IN CANCER-CHEMOTHERAPY - USEFULNESS IN CLINICAL-PRACTICE, Cancer treatment reviews, 23(3), 1997, pp. 153-169
Authors:
DIRIX L
CATIMEL G
VERDONK R
DEBRUIJN E
TRANCHAND B
ARDIET C
VANOOSTEROM A
Citation: L. Dirix et al., PHASE-I AND PHARMACOKINETIC STUDY OF KW-2149 GIVEN BY 24 HOURS CONTINUOUS-INFUSION, Investigational new drugs, 13(2), 1995, pp. 133-136